Sequential Double Claisen Rearrangement and Two-Directional Ring-Closing Metathesis as a Route to Various Benzofused Bisoxepin and Bisoxocin Derivatives

Shital K. Chattopadhyay; Titas Biswas; Susama Maity

doi:10.1055/s-2006-950398

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2006(14): 2211-2214
DOI: 10.1055/s-2006-950398

LETTER

Sequential Double Claisen Rearrangement and Two-Directional Ring-Closing Metathesis as a Route to Various Benzofused Bisoxepin and Bisoxocin Derivatives

Shital K. Chattopadhyay*, Titas Biswas, Susama Maity
Department of Chemistry, University of Kalyani, Kalyani - 741235, India
Fax: skchatto@yahoo.com; e-Mail: +91(33)25828282;

Further Information

Publication History

Received 14 February 2006
Publication Date:
24 August 2006 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A synthetic strategy based on tandem application of double Claisen rearrangement and two-directional ring-closing metathesis reaction as key-steps has been developed for the synthesis of various hitherto unknown tri-, tetra- and pentacyclic benzofused bisoxepin and bisoxocin derivatives.

Key words

Claisen rearrangement - ring-closing metathesis - oxepine - oxocine

References and Notes

1 Stefinovic M. Snieckus V. J. Org. Chem. 1998, 63: 2808

Crossref Google Scholar
2a Kishuku H. Shindo M. Shishido K. Chem. Commun. 2003, 350

Crossref Google Scholar
2b Sabui SK. Venkateswaran RV. Tetrahedron Lett. 2004, 45: 983

Crossref Google Scholar
2c Lecornue F. Ollivier J. Synlett 2004, 1613

Crossref Google Scholar
2d Vyvyan JR. Oaksmith JM. Parks BW. Peterson EM. Tetrahedron Lett. 2005, 46: 2457

Crossref Google Scholar
3 Huang S. Kuo H. Chen C. Tetrahedron Lett. 2001, 42: 7473

Crossref Google Scholar
4 Satoh Y. Libby AH. Powers C. Kowalski T. White DH. Kimble EF. Bioorg. Med. Chem. Lett. 1994, 4: 549

Crossref Google Scholar
5 Kiyama R. Honma T. Hayashi K. Ogawa M. Hara M. Fujimoto M. Fujishita T. J. Med. Chem. 1995, 38: 2728

Crossref Google Scholar
6 Carl K, and Joseph L. inventors; US 4,073,912; Chem. Abstr. . 1978, 89, 24156
7 For a review, see: Yet L. Chem. Rev. 2000, 100: 2963

Google Scholar
For some recent applications of RCM reaction in medium ring heterocycle formation, see:
8a Barberis M. Losada PG. Pleite S. Rodriguez JR. Soriano JF. Mendiola J. Tetrahedron Lett. 2005, 46: 4847

Article in Thieme Connect Google Scholar
8b Gracias V. Gasiecki AF. Djuric SW. Org. Lett. 2005, 7: 3183

Article in Thieme Connect Google Scholar
8c Kim YJ. Lee D. Org. Lett. 2004, 6: 4351

Article in Thieme Connect Google Scholar
8d Lane C. Snieckus V. Synlett 2000, 1294

Article in Thieme Connect Google Scholar
9a Chattopadhyay SK. Maity S. Panja S. Tetrahedron Lett. 2002, 43: 7781

Article in Thieme Connect Google Scholar
9b Chattopadhyay SK. Dey R. Biswas S. Synthesis 2005, 403

Article in Thieme Connect Google Scholar
10 Kotha S. Mandal K. Tetrahedron Lett. 2004, 45: 1391

Crossref Google Scholar
11 Pain C. Celanire S. Guillaunet G. Joseph B. Synlett 2003, 2089

Article in Thieme Connect Google Scholar
12a Wallace DJ. Tetrahedron Lett. 2005, 46: 591

Article in Thieme Connect Google Scholar
12b Clark JS. Hamelin O. Angew. Chem. Int. Ed. 2000, 39: 372

Article in Thieme Connect Google Scholar
12c Bassindale MJ. Hamley P. Leituer A. Harrity JPA. Tetrahedron Lett. 1999, 40: 3247

Article in Thieme Connect Google Scholar
12d Fang Z. Hong JH. Org. Lett. 2004, 6: 993

Article in Thieme Connect Google Scholar
12e Ahmed A. Ohler E. Mulzer J. Synthesis 2001, 2007

Article in Thieme Connect Google Scholar
13 Chattopadhyay SK. Paul BK. Maity S. Chem. Lett. 2003, 32: 1190

Crossref Google Scholar
14 Schlosser M. Michel D. Croft SL. Synthesis 1996, 591

Article in Thieme Connect Google Scholar
15a Kong Z.-L. Tzeng S.-C. Liu Y.-C. Bioorg. Med. Chem. Lett. 2005, 15: 163

Crossref Google Scholar
15b Pearson DPG. Leigh SJ. Sutherland IO. J. Chem. Soc., Perkin Trans. 1 1979, 3113

Crossref Google Scholar
15c Sorrell TN. Ellis DJ. J. Org. Chem. 1985, 50: 5765

Crossref Google Scholar
16 Ithart A. Plubrukarn A. Kongsaeree P. Bui T. Keawpradub N. Houghton PJ. Org. Lett. 2003, 5: 2879

Crossref Google Scholar
17 Takahasi I. Nomura A. Kitajama H. Synth. Commun. 1990, 20: 1569

Google Scholar
18 Cambie RC. Howe TA. Pausler MG. Rutledge PS. Woodgate PD. Aust. J. Chem. 1987, 40: 1063

Google Scholar

19

General Procedure for the Synthesis of the Bisdienes.
A heterogeneous mixture of the appropriate biphenol (1.0 mmol), allyl bromide (or 4-bromobutene; 4.0 mmol), anhyd K₂CO₃ (8.0 mmol) and dry acetone (10 mL) was refluxed under stirring under nitrogen atmosphere for 18 h. It was then filtered and the filter cake was washed with acetone (2 × 10 mL). The combined acetone solution was then concentrated in vacuo and the residual mass was chromatographed over silica gel.
Data for compound 3: ¹H NMR (300 MHz, CDCl₃): δ = 6.84 (s, 1 H), 6.13-5.91 (m, 4 H), 5.45 (dd, 2 H, J = 17.1, 1.2 Hz), 5.27 (d, 2 H, J = 9.4 Hz), 5.08 (overlapping doublets, 4 H), 4.28 (d, 4 H, J = 5.4 Hz), 3.36 (d, 4 H, J = 6.5 Hz), 2.22 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 153.9 (s), 137.2 (d), 129.4 (d), 128.7 (d), 125.0 (s), 115.8 (t), 111.4 (s), 75.1 (t), 34.1 (t), 10.7 (q). Anal. Calcd for C₁₉H₂₄O₂: C, 80.24; H, 8.51. Found: C, 80.48; H, 8.39.
Compound 10: ¹H NMR (300 MHz, CDCl₃): δ = 6.67 (s, 2 H), 6.04-5.96 (m, 4 H), 5.42 (dd, 2 H, J = 17.2, 1.4 Hz), 5.22 (dd, 2 H, J = 10.4, 1.1 Hz), 5.04-5.01 (m, 4 H), 4.48 (d, 4 H, J = 1.2 Hz), 3.37 (d, 4 H, J = 6.3 Hz). ¹³C NMR (75 MHz, CDCl₃): δ = 150.3 (s), 137.1 (d), 133.8 (d), 127.5 (s), 116.8 (t), 115.4 (t), 114.5 (d), 69.8 (t), 34.2 (t). Anal. Calcd for C₁₈H₂₂O₂: C, 79.96; H, 8.20. Found: C, 80.07; H, 8.23.
Compound 16: mp 82 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.40-7.34 (m, 4 H), 6.88 (d, 2 H, J = 9.1 Hz), 6.15-5.98 (m, 4 H), 5.45 (d, 2 H, J = 17.4 Hz), 5.29 (d, 2 H, J = 9.6 Hz), 5.14-5.05 (m, 4 H), 4.58 (d, 4 H, J = 4.8 Hz), 3.48 (d, 4 H, J = 6.5 Hz). ¹³C NMR (75 MHz, CDCl₃): δ = 155.3 (s), 136.9 (d), 133.5 (d), 133.4 (d), 129.0 (s), 128.3 (s), 125.3 (d), 116.8 (t), 115.4 (t), 111.8 (d), 68.8 (t), 34.5 (t).
Compound 28: ¹H NMR (300 MHz, CDCl₃): δ = 7.82 (d, 2 H, J = 8.4 Hz), 7.32 (d, 2 H, J = 8.5 Hz), 6.26-6.15 (m, 2 H), 6.08-5.99 (m, 2 H), 5.51 (dd, 2 H, J = 17.4, 1.4 Hz), 5.32 (dd, 2 H, J = 11.2, 1.0 Hz), 5.13-5.07 (m, 4 H), 4.49 (d, 4 H, J = 5.4 Hz), 3.59 (d, 4 H, J = 6.3 Hz). ¹³C NMR (75 MHz, CDCl₃): δ = 152.5 (s), 137.2 (d), 133.9 (d), 128.9 (s), 128.3 (d), 128.0 (s), 118.3 (d), 117.3 (t), 115.9 (t), 75.3 (t), 33.9 (t). Anal. Calcd for C₂₂H₂₄O₂: C, 82.46; H, 7.55. Found: C, 82.57; H, 7.64.
Compound 34: mp 98 °C. IR (KBr,): 1669, 1258, 1073, 993 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 8.04 (d, 2 H, J = 7.9 Hz), 7.60 (d, 2 H, J = 7.9 Hz), 6.27-6.16 (m, 2 H), 6.02-5.94 (m, 2 H), 5.44 (dd, 2 H, J = 17.2, 1.0 Hz), 5.32 (d, 2 H, J = 10.1 Hz), 5.16-5.09 (m, 4 H), 4.54 (d, 4 H, J = 5.6 Hz), 3.55 (d, 4 H, J = 6.4 Hz). ¹³C NMR (75 MHz, CDCl₃): δ = 180.5 (s), 156.7 (s), 141.6 (s), 135.7 (d), 135.5 (s), 133.7 (d), 125.3 (s), 123.4 (d), 118.0 (t), 117.0 (t), 75.2 (t), 34.2 (t). Anal. Calcd for C₂₆H₂₄O₄: C, 77.98; H, 6.04. Found: C, 78.11; H, 6.20.

20

General Procedure for TDRCM.
To a solution of the appropriate bisdiene (0.2 mmol) in dry, degassed CH₂Cl₂ (25 mL) was added Grubbs’ catalyst (5, 15 mg, 10 mol%) under argon atmosphere and the resulting solution was stirred at r.t. for the time indicated in Table [1] . The solvent was the removed in vacuo and the residue was chromatographed over silica gel.

21

All new compounds reported here gave satisfactory spectroscopic and/or analytical data.
Compound 6: mp 140-141 °C. ¹H NMR (300 MHz, CDCl₃): δ = 6.65 (s, 1 H), 5.85-5.79 (m, 2 H), 5.43 (d, 2 H, J = 11.5 Hz), 4.53 (s, 4 H), 3.37 (d, 4 H, J = 2.5 Hz), 2.20 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 155.5 (s), 131.5 (s), 127.3 (d), 126.0(d), 125.1 (d), 123.4 (s), 70.0(t), 31.3 (t), 8.9 (q). Anal. Calcd for C₁₅H₁₆O₂: C, 78.92; H, 7.06. Found: C, 79.18; H, 7.21. MS (EI): m/z = 228 [M⁺].
Compound 7: ¹H NMR (300 MHz, CDCl₃): δ = 6.77 (s, 1 H), 5.91-5.84 (m, 2 H), 5.68-5.62 (m, 2 H), 3.95 (t, 4 H, J = 4.7 Hz), 3.32 (d, 4 H, J = 7.0 Hz), 2.44-2.39 (m, 4 H), 2.15 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 154.7 (s), 134.0 (d), 133.1 (s), 126.9 (d), 125.9 (d), 125.4 (s), 71.9 (t), 31.4 (t), 28.8 (t), 9.6 (q). Anal. Calcd for C₁₇H₂₀O₂: C, 79.65; H, 7.86. Found: C, 79.78; H, 8.01.
Compound 12: mp 143 °C. ¹H NMR (300 MHz, CDCl₃): δ = 6.79 (s, 2 H), 5.85-5.79 (m, 2 H), 5.45 (td, 2 H, J = 11.4, 1.4 Hz), 4.54 (d, 4 H, J = 2.2 Hz), 3.41 (s, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 154.5 (s), 135.0 (s), 127.4 (d), 125.6 (d), 121.6 (d), 71.2 (t), 31.3 (t). MS (EI): m/z = 214 (100).
Compound 13: ¹H NMR (300 MHz, CDCl₃): δ = 6.80 (s, 2 H), 5.98-5.87 (m, 2 H), 5.18-5.01 (m, 2 H), 3.95 (t, 4 H, J = 6.5 Hz), 3.35-3.26 (m, 4 H), 2.54-2.51 (m, 4 H). Anal. Calcd for C₁₆H₁₈O₂: C, 79.31; H, 7.49. Found: C, 79.39; H, 7.52.
Compound 18: mp 104 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.34 (dd, 2 H, J = 8.2, 2.3 Hz), 7.25 (d, 2 H, J = 2.8 Hz), 7.10 (d, 2 H, J = 8.1 Hz), 5.93-5.84 (m, 2 H), 5.52-5.47 (m, 2 H), 4.62-4.60 (m, 4 H), 3.53 (d, 4 H, J = 2.8). ¹³C NMR (75 MHz, CDCl₃): δ = 158.0 (s), 136.7 (s), 136.2 (s), 127.5 (d), 127.3 (d), 126.3 (d), 125.7 (d), 121.7 (d), 71.2 (t), 31.9 (t). MS (EI): m/z = 290 [M⁺]. Anal. Calcd for C₂₀H₁₈O₂: C, 82.73; H, 6.25. Found: C, 82.91; H, 6.44.
Compound 19: mp 80 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.37-7.34 (m, 4 H), 7.05 (d, 2 H, J = 8.4 Hz), 5.94 (td, 2 H, J = 10.9, 6.6 Hz), 5.69-5.60 (m, 2 H), 4.08 (t, 4 H, J = 4.9 Hz), 3.46 (d, 4 H, J = 6.5 Hz), 2.41-2.36 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 156.7 (s), 136.2 (s), 135.8 (s), 127.1 (d), 126.9 (d), 125.8 (d), 124.3 (d), 122.0 (d), 72.1 (t), 32.1 (t), 28.4 (t). Anal. Calcd for C₂₂H₂₂O₂: C, 82.99; H, 6.96. Found: C, 82.91; H, 6.64.
Compound 24: ¹H NMR (300 MHz, CDCl₃): δ = 7.19-7.05 (m, 6 H), 5.87-5.80 (m, 2 H), 5.39 (d, 2 H, J = 11.4 Hz), 4.36 (t, 4 H, J = 2.1 Hz), 3.54 (d, 4 H, J = 2.4 Hz). ¹³C NMR (75 MHz, CDCl₃): δ = 155.8 (s), 136.6 (s), 132.0 (s), 129.3 (d), 128.1 (d), 127.5 (d), 125.3 (d), 123.4 (d), 70.4 (t), 31.8 (t). MS (EI): m/z = 290 [M⁺]. Anal. Calcd for C₂₀H₁₈O₂: C, 82.73; H, 6.25. Found: C, 82.84; H, 6.32.
Compound 25: ¹H NMR (300 MHz, CDCl₃): δ = 7.17-7.14 (m, 4 H), 7.05 (d, 2 H, J = 7.4 Hz), 5.94 (td, 2 H, J = 10.9, 6.9 Hz), 5.59 (td, 2 H, J = 10.8, 7.3 Hz), 3.63 (t, 4 H, J = 4.9 Hz), 3.47 (d, 4 H, J = 6.7 Hz), 2.30-2.25 (m, 4 H). HRMS (TOF MS ES⁺): m/z calcd.: 318.1619; found: 318.1628.
Compound 30: ¹H NMR (300 MHz, CDCl₃): δ = 7.85 (d, 2 H, J = 6.3 Hz), 7.23 (d, 2 H, J = 6.4 Hz), 5.93-5.89 (m, 2 H), 5.54 (dquint, 2 H, J = 8.7, 1.0 Hz), 4.70-4.68 (m, 4 H), 3.64-3.62 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 153.7 (s), 130.8 (s), 128.4 (s), 127.5 (d), 125.7 (d), 117.0 (d), 70.1 (t), 32.0(t). MS (EI): m/z = 264 [M⁺].
Compound 31: mp 176-178 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.78 (d, 2 H, J = 8.4 Hz), 7.33 (d, 2 H, J = 9.1 Hz), 6.02 (dt, 2 H, J = 10.7, 7.1 Hz), 5.63 (dt, 2 H, J = 10.7, 7.3 Hz), 4.18 (t, 4 H, J = 4.7 Hz), 3.54 (d, 4 H, J = 7.1 Hz), 2.51-2.46 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 152.4 (s), 133.6 (d), 132.6 (s), 129.3 (s), 127.6 (d), 127.3 (d), 117.7 (d), 72.6 (t), 31.7 (t), 29.0 (t). Anal. Calcd for C₂₀H₂₀O₂: C, 82.16; H, 6.89. Found: C, 82.33; H, 7.02. MS (EI): m/z = 292 [M⁺].
Compound 35: mp 248-251 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.97 (d, 2 H, J = 7.9 Hz), 7.48 (d, 2 H, J = 7.8 Hz), 5.88-5.85 (m, 2 H), 5.53 (d, 2 H, J = 11.0 Hz), 4.83 (s, 4 H), 3.58 (s, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 183.0 (s), 158.2 (s), 146.4 (s), 135.6 (s), 133.8 (d), 128.3 (d), 126.3 (s), 124.7 (d), 123.9 (d), 71.1 (t), 31.1 (t). Anal. Calcd for C₂₂H₁₆O₄: C, 76.73; H, 4.68. Found: C, 76.94; H, 4.62. MS (TOF MS ES⁺): m/z = 344 [M⁺].